Trial Profile
Clinical Trials Insight: 700045744
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2009
Price :
$35
*
At a glance
- Drugs Rindopepimut (Primary) ; Antineoplastics
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Celldex Therapeutics Inc; Pfizer
- 09 Jun 2009 New trial record.